Cleared Traditional

K872056 - MODIFIED (DIRECTIONS FOR USE) FOR IDEIA...

K872056 is the FDA 510(k) clearance for MODIFIED (DIRECTIONS FOR USE) FOR IDEIA... by Boots-Celltech Diagnostics, Inc.. It is a Class 1 Microbiology device (product code LJC) cleared through the Traditional 510(k) pathway after a 18-day FDA review.

K872056 · Boots-Celltech Diagnostics, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1987
Decision
18d
Days
Class 1
Risk

K872056 is an FDA 510(k) clearance for the MODIFIED (DIRECTIONS FOR USE) FOR IDEIA(TM) TEST. Classified as Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group) (product code LJC), Class I - General Controls.

Submitted by Boots-Celltech Diagnostics, Inc. (Berkshire, England, GB). The FDA issued a Cleared decision on June 15, 1987 after a review of 18 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3120 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Boots-Celltech Diagnostics, Inc. devices

Submission Details

510(k) Number K872056 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 28, 1987
Decision Date June 15, 1987
Days to Decision 18 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
84d faster than avg
Panel avg: 102d · This submission: 18d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LJC Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3120
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LJC Enzyme Linked Immunoabsorbent Assay, (chlamydiae Group)

All 47
Devices cleared under the same product code (LJC) and FDA review panel - the closest regulatory comparables to K872056.
ABBOTT TESTPACK(TM) CHLAMYDIA POSITIVE CONTROL
K882535 · Abbott Laboratories · Jul 1988
CHLAMYDIAZYME(TM)
K880469 · Abbott Laboratories · May 1988
PATHFINDER(TM) CHLAMYDIA EIA DETECTION KIT
K880824 · Kallestad Diag, A Div. of Erbamont, Inc. · Apr 1988
CHLAMYDIAZYME DIAGNOSTIC KIT
K864842 · Abbott Laboratories · Apr 1987
ORTHO* CHLAMYDIA ANTIGEN ELISA TEST & TRANSPORT
K863490 · Ortho Diagnostic Systems, Inc. · Nov 1986
VISIBLE-CHLAMYDIA(TM) TEST SYSTEM
K862638 · Isolab, Inc. · Aug 1986